EPO Patents = 10

Trademarks = 3

Forward Citations = 5

Loading Chart...

3 inventors (with patents filed for the assignee):

Fritz Eichenseher (7 out of 7 patents)

Martin Johannes Loessner (6 out of 7 patents)

Mark Leonard Offerhaus (1 out of 2 patents)

4. Bjorn Lars Herpers (1 patent)

5. Fritz Eichenseher (0 patent)

6. Mathias Schmelcher (0 patent)

7. Christian Alexander RÖHRIG (0 patent)

7 patents: Sort by Forward Citations

1. 11690899 - Combination of bactericidal agent with a lysosomotropic alkalinising agent for the treatment of a bacterial infection (2023-07-04),

2. 11339386 - Endolysin polypeptide (2022-05-24),

3. 10829749 - Endolysin polypeptide (2020-11-10),

4. 10357547 - Combination treatment for atopic dermatitis (2019-07-23),

5. 10174300 - Polypeptide (2019-01-08),

6. 9789167 - Polypeptide mixes with antibacterial activity (2017-10-17),

7. 9382298 - Polypeptide (2016-07-05),

Micreos Human Health B.v. is a biotechnology company focused on developing innovative solutions to combat antibiotic-resistant bacteria. Their flagship product, Staphefekt, is a targeted endolysin that specifically kills Staphylococcus aureus bacteria without harming beneficial bacteria. Micreos is dedicated to improving human health through the use of precision antibacterial technology.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

7 Patents

#10 in The Hague

#825 in Netherlands

The Hague, Netherlands

Micreos Human Health B.v.